Abstract
A range of 5,6-bisindole and 5-indole-6-(7-azaindole)pyrimidinones were synthesised via a β-keto ester intermediate and a screen of cyclisation conditions undertaken. The optimised route to this new class of indolocarbazoles and azaindolocarbazoles involved photocyclisation, with typical yields of 50-60%. These derivatives were screened for anti-cancer activity via topo II inhibition and the NCI-60 cell line assay, with the screening indicating a lack of topo II inhibition, but significant in vitro growth inhibition within this new chemical class, in the low micromolar range against renal cancer, melanoma and colon cancer cell lines.
| Original language | English |
|---|---|
| Pages (from-to) | 292-300 |
| Number of pages | 9 |
| Journal | European Journal of Medicinal Chemistry |
| Volume | 56 |
| DOIs | |
| Publication status | Published - Oct 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anti-cancer
- Azaindolocarbazoles
- Bisindolylmaleimides
- Indolocarbazoles
- Photocyclisation
- Pyrimidines
- Topoisomerase II
Fingerprint
Dive into the research topics of 'Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c] carbazoles as a new class of anti-cancer agents'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver